Furosemide (versus unexposed) updated on 03-11-2025

Table   Graphic     exposition period:

Congenital malformations
Adverse outcome OR 95%CII2k No. casesNo. exposedpublication biasROBE-value
All congenital malformations (majors, minors, majors and minors, or unspecified)1.60 [0.79, 3.25]-1 study22,86529not evaluable ROB-
Ano-rectal atresia and stenosis5.60 [0.33, 93.96]-1 study22015not evaluable ROB-
Cleft lip with or without cleft palate1.90 [0.23, 15.95]-1 study1,36816not evaluable ROB-
Club foot / Talipes equinovarus2.20 [0.50, 9.74]-1 study2,41917not evaluable ROB-
Congenital heart defects1.20 [0.29, 5.04]-1 study4,46617not evaluable ROB-
Ear malformations3.51 [0.21, 58.78]-1 study35115not evaluable ROB-
Hydrocephaly3.96 [0.24, 66.36]-1 study31115not evaluable ROB-
Hypospadias1.80 [0.40, 8.05]-1 study3,03217not evaluable ROB-
Limb reduction defects (LRD)4.40 [0.59, 32.88]-1 study54516not evaluable ROB-
Major congenital malformations1.60 [0.79, 3.25]-1 study22,86529not evaluable ROB-
Neural Tube Defects2.00 [0.28, 14.33]-1 study1,19116not evaluable ROB-
Oesophageal atresia with or without tracheo-oesophageal fistula22.80 [5.18, 100.43]-1 study22917not evaluable ROB45.09 [9.83; .]
Polydactyly1.70 [0.21, 13.49]-1 study1,73016not evaluable ROB-

Hide endpoints reported in only one study ...